These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8978600)

  • 21. Immune signalling: SHP-2 docks at multiple ports.
    Huyer G; Alexander DR
    Curr Biol; 1999 Feb; 9(4):R129-32. PubMed ID: 10074424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The phosphatidylinositol polyphosphate 5-phosphatase SHIP and the protein tyrosine phosphatase SHP-2 form a complex in hematopoietic cells which can be regulated by BCR/ABL and growth factors.
    Sattler M; Salgia R; Shrikhande G; Verma S; Choi JL; Rohrschneider LR; Griffin JD
    Oncogene; 1997 Nov; 15(19):2379-84. PubMed ID: 9393882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Src homology region 2 (SH2) domain-containing phosphatase-1 dephosphorylates B cell linker protein/SH2 domain leukocyte protein of 65 kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells.
    Mizuno K; Tagawa Y; Mitomo K; Arimura Y; Hatano N; Katagiri T; Ogimoto M; Yakura H
    J Immunol; 2000 Aug; 165(3):1344-51. PubMed ID: 10903736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A mouse Fcgamma-Fcepsilon protein that inhibits mast cells through activation of FcgammaRIIB, SH2 domain-containing inositol phosphatase 1, and SH2 domain-containing protein tyrosine phosphatases.
    Mertsching E; Bafetti L; Hess H; Perper S; Giza K; Allen LC; Negrou E; Hathaway K; Hopp J; Chung J; Perret D; Shields M; Saxon A; Kehry MR
    J Allergy Clin Immunol; 2008 Feb; 121(2):441-447.e5. PubMed ID: 17949802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tyrosine phosphatase SHP-2 dephosphorylates the platelet-derived growth factor receptor but enhances its downstream signalling.
    Zhao R; Zhao ZJ
    Biochem J; 1999 Feb; 338 ( Pt 1)(Pt 1):35-9. PubMed ID: 9931295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Requirement of SH2-containing protein tyrosine phosphatases SHP-1 and SHP-2 for paired immunoglobulin-like receptor B (PIR-B)-mediated inhibitory signal.
    Maeda A; Kurosaki M; Ono M; Takai T; Kurosaki T
    J Exp Med; 1998 Apr; 187(8):1355-60. PubMed ID: 9547347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shp-2 tyrosine phosphatase: signaling one cell or many.
    Feng GS
    Exp Cell Res; 1999 Nov; 253(1):47-54. PubMed ID: 10579910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cytokine receptors and signal transduction].
    Nakajima H; Kitamura T
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():178-86. PubMed ID: 15861654
    [No Abstract]   [Full Text] [Related]  

  • 29. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
    Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
    J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Src-homology domain 2-bearing protein tyrosine phosphatase-1 inhibits antigen receptor-induced apoptosis of activated peripheral T cells.
    Zhang J; Somani AK; Watt S; Mills GB; Siminovitch KA
    J Immunol; 1999 Jun; 162(11):6359-67. PubMed ID: 10352248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of the SHP-2 tyrosine phosphatase in cytokine-induced signaling and cellular response.
    Qu CK
    Biochim Biophys Acta; 2002 Nov; 1592(3):297-301. PubMed ID: 12421673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular basis of the recruitment of the SH2 domain-containing inositol 5-phosphatases SHIP1 and SHIP2 by fcgamma RIIB.
    Bruhns P; Vely F; Malbec O; Fridman WH; Vivier E; Daeron M
    J Biol Chem; 2000 Dec; 275(48):37357-64. PubMed ID: 11016922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The tyrosine phosphatase SHP-1 is a negative regulator of osteoclastogenesis and osteoclast resorbing activity: increased resorption and osteopenia in me(v)/me(v) mutant mice.
    Aoki K; Didomenico E; Sims NA; Mukhopadhyay K; Neff L; Houghton A; Amling M; Levy JB; Horne WC; Baron R
    Bone; 1999 Sep; 25(3):261-7. PubMed ID: 10495129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor.
    Godeny MD; Sayyah J; VonDerLinden D; Johns M; Ostrov DA; Caldwell-Busby J; Sayeski PP
    Cell Signal; 2007 Mar; 19(3):600-9. PubMed ID: 17027227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leptin receptor activation of SH2 domain containing protein tyrosine phosphatase 2 modulates Ob receptor signal transduction.
    Li C; Friedman JM
    Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9677-82. PubMed ID: 10449753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2) can play a direct role in the inhibitory function of killer cell Ig-like receptors in human NK cells.
    Yusa S; Campbell KS
    J Immunol; 2003 May; 170(9):4539-47. PubMed ID: 12707331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Shp-2 has a positive regulatory role in ES cell differentiation and proliferation.
    Qu CK; Feng GS
    Oncogene; 1998 Jul; 17(4):433-9. PubMed ID: 9696036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of CD150-SH2D1A association in CD150 signaling in Hodgkin's lymphoma cell lines.
    Yurchenko MY; Kashuba EV; Shlapatska LM; Sivkovich SA; Sidorenko SP
    Exp Oncol; 2005 Mar; 27(1):24-30. PubMed ID: 15812353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
    Yusa S; Catina TL; Campbell KS
    J Immunol; 2002 May; 168(10):5047-57. PubMed ID: 11994457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B cell antigen receptor (BCR)-mediated formation of a SHP-2-pp120 complex and its inhibition by Fc gamma RIIB1-BCR coligation.
    Nakamura K; Cambier JC
    J Immunol; 1998 Jul; 161(2):684-91. PubMed ID: 9670943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.